AI Biomed PredictionsCRBP – Corbus Faces Its Next Real Repricing on TEMPO-1 Launch ScanScor Admin / June 9, 2026
AI Biomed PredictionsZNTL – ASCO follow-through could spark Zentalis’ next ovarian cancer rerating ScanScor Admin / May 31, 2026
AI Biomed PredictionsMAIA – Late-Stage NSCLC Progress Could Reawaken MAIA’s Microcap Upside ScanScor Admin / May 31, 2026
AI Biomed PredictionsIMRX – ASCO Data Will Decide Whether IMRX Earns Its Re-Rating ScanScor Admin / May 30, 2026
AI Biomed PredictionsCRDF – ASCO Data Could Decide Cardiff Oncology’s Next Sharp Repricing ScanScor Admin / May 28, 2026
AI Biomed PredictionsADAG – Next ADAG move likely hinges on execution, not hype ScanScor Admin / May 2, 2026
AI Biomed PredictionsMGNX – Mid-2026 data could decide MacroGenics’ turnaround trajectory ScanScor Admin / May 2, 2026
AI Biomed PredictionsOKUR – Cash-Rich OnKure Awaits Fall Data Validation for PI3K Thesis ScanScor Admin / May 2, 2026
AI Biomed PredictionsGTBP – GTB-5550 clinical launch may spark GTBP’s next rebound ScanScor Admin / April 30, 2026
AI Biomed PredictionsELTX – ELTX nears binary pancreatic cancer readout with breakout potential ScanScor Admin / April 21, 2026
